Keywords: ضد CD20; anti-CD20; autoimmune; biologics; blistering diseases; desmoglein; desmosomes; immunomodulators; immunosuppression; monoclonal antibodies; pemphigus vulgaris; rituximabADCC, antibody-dependent cell-mediated cytotoxicity; CDC, complement-dependent cytotoxi
مقالات ISI ضد CD20 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ضد CD20; Outcome measure; Biologics; Anti-CD20; BLyS; Registries; Lupus nephritis;
Keywords: ضد CD20; Anticancer therapy; Anti-CD20; Chemoimmunotherapy; Haematological toxicity; Secondary effects
Keywords: ضد CD20; Warm autoimmune hemolytic anemia; B-cell depletion; Anti-CD20; Antibody-secreting cells; Long-lived plasma cellswAIHA, warm autoimmune hemolytic anemia; BAFF, B-cell activating factor; ASC, antibody-secreting cells; LLPC, long-lived plasma cells; RTX, rit
Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma
Keywords: ضد CD20; Primary central nervous system lymphoma (PCNSL); Blood brain barrier (BBB); Brain lymphoma; Superparamagnetic iron oxide nanoparticle (SPIONs); Rituximab; Anti-CD20; Liposome; Theranostics;
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature
Keywords: ضد CD20; Scleroderma; Systemic sclerosis; Rituximab; Anti-CD20; Arthritis; Skin sclerosis; Lung fibrosis
Is Splenectomy Necessary for Immune Thrombocytopenic Purpura? The Role of Rituximab in Patients With Corticosteroid Resistance in a Single-Center Experience
Keywords: ضد CD20; anti-CD20; corticosteroid-resistant ITP; rituximab; splenectomy;
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register
Keywords: ضد CD20; Rheumatoid arthritis; Rituximab; Anti-CD20; Methotrexate
Rituximab-Based Chemoimmunotherapy Prolongs Survival of Patients With Chronic Lymphocytic Leukemia Independently of the Time of Administration
Keywords: ضد CD20; Anti-CD20; CLL; OS; Purine analogues; Treatment;
Original StudyRituximab With or Without Bevacizumab for the Treatment of Patients With Relapsed Follicular Lymphoma
Keywords: ضد CD20; Angiogenesis; Anti-CD20; Lymphoma; VEGF; VEGF inhibitor;
Design, expression and characterization of a single chain anti-CD20 antibody; a germline humanized antibody derived from Rituximab
Keywords: ضد CD20; Single chain antibody fragment; Anti-CD20; Germ line humanization;
ReviewHepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management
Keywords: ضد CD20; ADV; adefovir; AFP; alphafetoprotein; ALT; alanine aminotransferase; anti-CD20; CD20 antibodies; anti-TNF; anti-tumour necrosis factors; ART; antiretroviral therapy; BHN; bridging hepatic necrosis; cccDNA; covalently closed circular DNA; CHB; chronic hepa
Administration of Anti-CD20 mAb Is Highly Effective in Preventing but Ineffective in Treating Chronic Graft-Versus-Host Disease While Preserving Strong Graft-Versus-Leukemia Effects
Keywords: ضد CD20; Anti-CD20; GVHD; B cell depletion; Acute GVHD; Chronic GVHD; Therapy
B regulatory cells in cancer
Keywords: ضد CD20; B cells; B regulatory cells; interleukin-10; cancer; anti-CD20; immunosuppression
Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab
Keywords: ضد CD20; Catastrophic antiphospholipid syndrome; Refractory; Rituximab; Anti-CD20
Treatment of multiple sclerosis with Anti-CD20 antibodies
Keywords: ضد CD20; Multiple Sclerosis; Therapy; B cells; anti-CD20
B cells in systemic sclerosis: A possible target for therapy
Keywords: ضد CD20; Systemic sclerosis; B cells; Anti-CD20; Cytokines; Rituximab
Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: Results of multicenter cohort study and review of the literature
Keywords: ضد CD20; MCs, mixed cryoglobulinemia syndrome; HCV, hepatitis C virus; CR, complete response; PR, partial response; NR, no responder; MPGN, membranoproliferative glomerulonephritisMixed cryoglobulinemia; Cryoglobulinemic vasculitis; Rituximab; Anti-CD20; Hepatitis
Anémies hémolytiques auto-immunes : diagnostic biologique et nouvelles approches thérapeutiques
Keywords: ضد CD20; Anémie hémolytiques auto-immunes; Auto-anticorps; Test de Coombs; Anti-CD20; Gel test; RituximabAutoimmune haemolytic anemia; Direct antiglobulin Test; Coombs test; Gel test; Autoantibodies; Anti-CD20; Rituximab
B-cell Biology and Related Therapies in Systemic Lupus Erythematosus
Keywords: ضد CD20; B lymphocytes; Systemic lupus erythematosus; Anti-CD20; Rituximab; Belimumab; Atacicept;
Resolution of IgM Nephropathy After Rituximab Treatment
Keywords: ضد CD20; Immunoglobulin M (IgM) nephropathy; rituximab; anti-CD20; transplantation; nephrotic syndrome;
Treating severe systemic lupus erythematosus with rituximab. An open study
Keywords: ضد CD20; Systemic lupus erythematosus; Anti-CD20; Lupus nephritis; Neuropsychiatric involvement; Transverse myelitis; Massive pulmonary hemorrhage; Immunosuppressive therapy; Lupus eritematoso sistémico; Anticuerpo monoclonal; NefropatÃa lúpica; Manifestaciones
Monoclonal anti-CD20 antibodies: Mechanisms of action and monitoring of biological effects
Keywords: ضد CD20; B lymphocytes; Immunotherapy; Anti-CD20; Rituximab
Mécanismes de l’action des anticorps monoclonaux anti-CD20 et surveillance biologique de leurs effets
Keywords: ضد CD20; Lymphocytes B; Immunothérapie; Anti-CD20; RituximabB lymphocytes; Immunotherapy; Anti-CD20; Rituximab
Clinical applications of newer radionuclide therapies
Keywords: ضد CD20; Radionuclide therapy; mIBG; Octreotide; Radioimmunotherapy; Anti-CD20; Lipiodol; SIR-spheres
B cell depletion in autoimmune rheumatic diseases
Keywords: ضد CD20; WG; Wegener's granulomatosis; MPA; Microscopic polyangiitis; CSF; Cerebrospinal fluid; Anti-CD20; Rituximab; Autoimmune diseases; B cell depletion;
Liposomes targeted via two different antibodies: Assay, B-cell binding and cytotoxicity
Keywords: ضد CD20; DXR; doxorubicin; mAb; monoclonal antibody; SL; non-targeted long-circulating (Stealth®) liposomes; SIL; long-circulating antibody-targeted liposomes (Stealth® immunoliposomes); αCD19; anti-CD19 mAb; αCD20; anti-CD20 mAb (Rituxan); HSPC; hydrogenated